The first RIPTAC has just hit the clinic. Learn about this new technology that is being developed by Halda Therapeutics.

VantAI today unveiled Neo-1, the world’s most advanced atomistic foundation model and the first to unify de novo molecular ...

The buy-in is another endorsement of Arvinas' PROTAC drugs, bifunctional molecules that use one arm to bind to a target protein, and the other to an enzyme involved in the main ubiquitin ...

However, these inherent advantages also lead to diffusion limitations, preventing guest molecules from effectively ... they optimized the ZnAlO x-MOR bifunctional catalyst, achieving a CO ...

Zeolites and zeotypes are widely used in the energy and chemical industries due to their unique pore structures and excellent shape-selective ...

The treatment uses copper isotopes that are ‘held’ within a bifunctional cage (chelator ... hit a wider range of tumour targets than small molecules or small peptides. Importantly, the ...